Gland Pharma reports 20% fall in Q2 consolidated net profit

27 Oct 2022 Evaluate

Gland Pharma has reported results for second quarter ended September 30, 2022.

The company has reported a fall of 20.68% in its net profit at Rs 239.63 crore for the quarter under review as compared to Rs 302.12 crore for the same quarter in the previous year. Total income of the company decreased by 1.57% at Rs 1113.93 crore for Q2FY23 as compared Rs 1131.67 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported fall of 20.14% in its net profit at Rs 241.24 crore for the quarter under review as compared to Rs 302.08 crore for the same quarter in the previous year. Total income of the company decreased by 1.91% at Rs 1110.03 crore for Q2FY23 as compared Rs 1131.67 crore for the corresponding quarter previous year.

Gland Pharma Share Price

1665.20 15.30 (0.93%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×